SI1362590T1 - Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje - Google Patents

Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje

Info

Publication number: SI1362590T1
Authority: SI; Slovenia
Prior art keywords: cyclobradine; prevention; treatment; pharmaceutically acceptable; acceptable salts
Prior art date: 2002-07-25

Application number

SI200230008T

Other languages

English (en)

Inventor

Brian Guth Dr.

Randolf Seidler Dr.

J�rgen D�MMGEN Dr.

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co. Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2002-07-25

Publication date

2004-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1362590(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-25 Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg

2004-04-30 Publication of SI1362590T1 publication Critical patent/SI1362590T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI200230008T 2002-07-25 2002-07-25 Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje SI1362590T1 (sl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02016602A EP1362590B1 (en)	2002-07-25	2002-07-25	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Publications (1)

Publication Number	Publication Date
SI1362590T1 true SI1362590T1 (sl)	2004-04-30

Family

ID=29265956

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200230008T SI1362590T1 (sl)	2002-07-25	2002-07-25	Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje
SI200332021T SI1534296T1 (sl)	2002-07-25	2003-07-21	Uporaba cilobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje odpovedi srca

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200332021T SI1534296T1 (sl)	2002-07-25	2003-07-21	Uporaba cilobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje odpovedi srca

Country Status (29)

Country	Link
US (1)	US20130317008A1 (sl)
EP (2)	EP1362590B1 (sl)
JP (3)	JP2005533853A (sl)
KR (1)	KR20050074432A (sl)
CN (1)	CN100502874C (sl)
AR (1)	AR040690A1 (sl)
AT (2)	ATE257384T1 (sl)
AU (1)	AU2003254554B8 (sl)
BR (1)	BR0312852A (sl)
CA (1)	CA2493208C (sl)
CO (1)	CO5700723A2 (sl)
CY (1)	CY1112173T1 (sl)
DE (1)	DE60200160T2 (sl)
DK (2)	DK1362590T3 (sl)
ES (2)	ES2211846T3 (sl)
HR (1)	HRP20050075B1 (sl)
MX (1)	MXPA05000617A (sl)
MY (1)	MY128529A (sl)
NZ (1)	NZ538424A (sl)
PE (1)	PE20040706A1 (sl)
PL (1)	PL214716B1 (sl)
PT (2)	PT1362590E (sl)
SA (1)	SA03240350B1 (sl)
SI (2)	SI1362590T1 (sl)
TR (1)	TR200400127T4 (sl)
TW (1)	TWI319321B (sl)
UY (1)	UY27910A1 (sl)
WO (1)	WO2004011006A1 (sl)
ZA (1)	ZA200500084B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040138306A1 (en)	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1362590B1 (en) *	2002-07-25	2004-01-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20090247572A1 (en) *	2005-08-23	2009-10-01	Koichi Wada	Agent for treating atrial fibrillation
EP1762179A1 (en)	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr)	2008-02-14	2010-02-19	Servier Lab	Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
MX2014001556A (es) *	2011-08-12	2014-03-31	Boehringer Ingelheim Vetmed	Composicion farmaceutica de sabor enmascarado.
WO2014122248A1 (en)	2013-02-11	2014-08-14	Boehringer Ingelheim Vetmedica Gmbh	Kit-of-parts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175157A (en) *	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3541811A1 (de) *	1985-11-27	1987-06-04	Thomae Gmbh Dr K	Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) *	1987-10-30	1989-05-11	Thomae Gmbh Dr K	Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) *	1988-02-24	1989-09-07	Thomae Gmbh Dr K	Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) *	1998-06-03	2009-03-18	日産化学工業株式会社	インダン誘導体
WO2000075133A1 (en) *	1999-06-03	2000-12-14	Yamanouchi Pharmaceutical Co., Ltd.	Novel isoquinoline derivatives or salts thereof
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
EP1362590B1 (en) *	2002-07-25	2004-01-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

2002
- 2002-07-25 EP EP02016602A patent/EP1362590B1/en not_active Expired - Lifetime
- 2002-07-25 DE DE60200160T patent/DE60200160T2/de not_active Expired - Lifetime
- 2002-07-25 PT PT02016602T patent/PT1362590E/pt unknown
- 2002-07-25 SI SI200230008T patent/SI1362590T1/sl unknown
- 2002-07-25 ES ES02016602T patent/ES2211846T3/es not_active Expired - Lifetime
- 2002-07-25 TR TR2004/00127T patent/TR200400127T4/xx unknown
- 2002-07-25 AT AT02016602T patent/ATE257384T1/de active
- 2002-07-25 DK DK02016602T patent/DK1362590T3/da active
2003
- 2003-07-21 WO PCT/EP2003/007929 patent/WO2004011006A1/en not_active Ceased
- 2003-07-21 BR BR0312852-0A patent/BR0312852A/pt not_active Application Discontinuation
- 2003-07-21 ES ES03771064T patent/ES2367109T3/es not_active Expired - Lifetime
- 2003-07-21 MX MXPA05000617A patent/MXPA05000617A/es active IP Right Grant
- 2003-07-21 NZ NZ538424A patent/NZ538424A/en not_active IP Right Cessation
- 2003-07-21 DK DK03771064.7T patent/DK1534296T3/da active
- 2003-07-21 AT AT03771064T patent/ATE510543T1/de active
- 2003-07-21 CA CA2493208A patent/CA2493208C/en not_active Expired - Fee Related
- 2003-07-21 AU AU2003254554A patent/AU2003254554B8/en not_active Ceased
- 2003-07-21 PL PL372993A patent/PL214716B1/pl unknown
- 2003-07-21 EP EP03771064A patent/EP1534296B1/en not_active Expired - Lifetime
- 2003-07-21 HR HRP20050075AA patent/HRP20050075B1/hr not_active IP Right Cessation
- 2003-07-21 JP JP2004523757A patent/JP2005533853A/ja active Pending
- 2003-07-21 SI SI200332021T patent/SI1534296T1/sl unknown
- 2003-07-21 CN CNB03817829XA patent/CN100502874C/zh not_active Expired - Fee Related
- 2003-07-21 PT PT03771064T patent/PT1534296E/pt unknown
- 2003-07-21 KR KR1020057001298A patent/KR20050074432A/ko not_active Ceased
- 2003-07-23 MY MYPI20032768A patent/MY128529A/en unknown
- 2003-07-24 TW TW092120260A patent/TWI319321B/zh not_active IP Right Cessation
- 2003-07-24 PE PE2003000735A patent/PE20040706A1/es not_active Application Discontinuation
- 2003-07-25 AR AR20030102678A patent/AR040690A1/es not_active Application Discontinuation
- 2003-07-31 UY UY27910A patent/UY27910A1/es not_active Application Discontinuation
- 2003-10-19 SA SA03240350A patent/SA03240350B1/ar unknown
2005
- 2005-01-05 ZA ZA2005/00084A patent/ZA200500084B/en unknown
- 2005-02-24 CO CO05017675A patent/CO5700723A2/es not_active Application Discontinuation
2009
- 2009-08-06 JP JP2009183392A patent/JP2009256379A/ja active Pending
2011
- 2011-08-24 CY CY20111100812T patent/CY1112173T1/el unknown
2013
- 2013-05-21 JP JP2013107160A patent/JP2013166781A/ja active Pending
- 2013-08-01 US US13/956,918 patent/US20130317008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60200160T2 (de)	2004-11-04
BR0312852A (pt)	2005-04-19
HRP20050075A2 (en)	2005-12-31
AR040690A1 (es)	2005-04-13
CO5700723A2 (es)	2006-11-30
PE20040706A1 (es)	2004-12-06
TR200400127T4 (tr)	2004-02-23
EP1362590B1 (en)	2004-01-07
WO2004011006A1 (en)	2004-02-05
NZ538424A (en)	2006-10-27
TW200412974A (en)	2004-08-01
EP1362590A8 (en)	2004-02-25
CN100502874C (zh)	2009-06-24
DE60200160D1 (de)	2004-02-12
AU2003254554A1 (en)	2004-02-16
PT1362590E (pt)	2004-05-31
ZA200500084B (en)	2005-10-26
JP2005533853A (ja)	2005-11-10
ATE510543T1 (de)	2011-06-15
EP1534296A1 (en)	2005-06-01
EP1362590A1 (en)	2003-11-19
CY1112173T1 (el)	2015-12-09
UY27910A1 (es)	2004-02-27
TWI319321B (en)	2010-01-11
JP2013166781A (ja)	2013-08-29
PL214716B1 (pl)	2013-09-30
HRP20050075B1 (hr)	2013-12-20
CA2493208A1 (en)	2004-02-05
KR20050074432A (ko)	2005-07-18
EP1534296B1 (en)	2011-05-25
PL372993A1 (en)	2005-08-08
US20130317008A1 (en)	2013-11-28
ES2211846T3 (es)	2004-07-16
CN1671392A (zh)	2005-09-21
MXPA05000617A (es)	2005-08-19
JP2009256379A (ja)	2009-11-05
ATE257384T1 (de)	2004-01-15
MY128529A (en)	2007-02-28
AU2003254554B8 (en)	2009-02-26
CA2493208C (en)	2011-11-01
PT1534296E (pt)	2011-08-18
SI1534296T1 (sl)	2011-09-30
DK1362590T3 (da)	2004-03-29
SA03240350B1 (ar)	2007-10-29
ES2367109T3 (es)	2011-10-28
DK1534296T3 (da)	2011-08-15
AU2003254554B2 (en)	2009-01-29

Publication	Publication Date	Title
LTC1830843I2 (lt)	2017-03-10	Indolidono dariniai, skirti fibrozinių ligų gydymui arba prevencijai
PT1485127E (pt)	2011-09-07	Administração de agentes para o tratamento de inflamação
CY2014028I1 (el)	2015-12-09	Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
HUS2200036I1 (hu)	2022-08-28	Dihidroimidazolonok alkalmazása kutyák kezelésére
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1894564T3 (da)	2011-08-29	Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation
PT1531819E (pt)	2009-02-18	Utilização de inibidores da i capa b cinase na terapia da dor
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
WO2006074265A3 (en)	2007-06-14	Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
AU2003258145A8 (en)	2004-02-25	Substituted phenylindoles for the treatment of hiv
ZA200510170B (en)	2006-11-29	Method of reducing the harmful effects of orally or transdermally delivered nicotine
SI1362590T1 (sl)	2004-04-30	Uporaba ciklobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje
PL375564A1 (en)	2005-11-28	Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
NO20040497L (no)	2004-04-14	Amidinderivater for behandling av amyloidose
ZA200606065B (en)	2007-12-27	Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
GB2410744B (en)	2006-04-12	Kinase inhibitors for the treatment of disease
ZA200605302B (en)	2007-04-25	Use of pentadienoic acid derivatives for the treatment of hyperuricemia
IL170706A0 (en)	2009-02-11	Use of atii antagonist for the treatment or prevention of metabolic syndrome
DK1414421T3 (da)	2008-12-08	Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet
HK1085397A (en)	2006-08-25	Use of atii antagonist for the treatment or prevention of metabolic syndrome
DK1519732T3 (da)	2012-06-18	Anvendelse af inhibitorer af vasopeptidase til behandling af nefropati
FI20021275A0 (fi)	2002-06-28	Terapeuttiset koostumukset käytettäväksi ripulien ehkäisyyn tai hoitoon
ES1054336Y (es)	2004-02-16	"ducha ortopedica para discapacitados"
HK1072011A (en)	2005-08-12	Use of posaconazole for the treatment of fungal infections